(Q38782421)

6 September 2017

The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury (English)

1 reference

6 September 2017

Yu Wu

1

1 reference

6 September 2017

Xing-chao Geng

2

1 reference

6 September 2017

Ju-feng Wang

3

1 reference

6 September 2017

Yu-fa Miao

4

1 reference

6 September 2017

Yan-li Lu

5

1 reference

6 September 2017

Bo Li

6

1 reference

6 September 2017

30 March 2016

1 reference

Cell Biology and Toxicology

6 September 2017

23

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 September 2017

32

1 reference

6 September 2017

37-59

1 reference

6 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s10565-016-9316-2

6 September 2017

0 references

cites work

Drug-induced liver injury: an overview over the most critical compounds

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

RUCAM in Drug and Herb Induced Liver Injury: The Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Mechanism-based selection of compounds for the development of innovative in vitro approaches to hepatotoxicity studies in the LIINTOP project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Infection of a human hepatoma cell line by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Basement membrane and matrix metalloproteinases in monocrotaline-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Human fetal hepatocyte line, L-02, exhibits good liver function in vitro and in an acute liver failure model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Carnitine in the treatment of valproic acid-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Triptolide: progress on research in pharmacodynamics and toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Cytochrome p450-mediated metabolic activation of diosbulbin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Drug-related hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

A high content screening assay to predict human drug-induced liver injury during drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Drug-induced liver injury: is it somehow foreseeable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Drug-induced liver injury due to “natural products” used for weight loss: A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Drug-induced liver injury: expanding our knowledge by enlarging population analysis with prospective and scoring causality assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Multiparametric assay using HepaRG cells for predicting drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Functional expression, inhibition and induction of CYP enzymes in HepaRG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Bioinformatic and image analyses of the cellular localization of the apoptotic proteins endonuclease G, AIF, and AMID during apoptosis in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Effects of phenobarbital on metabolism and toxicity of diclofenac sodium in rat hepatocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Construction and application of dynamic protein interaction network based on time course gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Endoplasmic reticulum stress: cell life and death decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

Cellular imaging predictions of clinical drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

FDA-approved drug labeling for the study of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10565-016-9316-2

10.1007/S10565-016-9316-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference